Venus Remedies Limited
Clinical trials sponsored by Venus Remedies Limited, explained in plain language.
An Indian pharmaceutical company that develops and manufactures generic drugs and active pharmaceutical ingredients.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New antibiotic formula aims to protect kidneys Results expected Oct 2026 (estimated)